Clinical Observation of 32 Cases of Malignant Lymphoma Treated with Brentuximab Vedotin Combined with Chemotherapy

Clinical Observation of 32 Cases of Malignant Lymphoma Treated with Brentuximab Vedotin Combined with Chemotherapy

Objective To retrospectively evaluate the clinical efficacy and safety of brentuximab vedotin(BV) combined with chemotherapy in the treatment of malignant lymphoma. Methods We collected the data of 32 lymphoma patients with CD30-positive status, including 14 cases of Hodgkin's lymphomas, 2 case...

Full description

Bibliographic Details
Main Authors: CHAI Xiaofei, QIAO Honghan, ZHANG Lei, LI Xin, LI Ling, WANG Xinhua, FU Xiaorui, ZHANG Xudong, SUN Zhenchang, NAN Feifei, ZHANG Mingzhi
Format: Article
Language:zho
Published: Magazine House of Cancer Research on Prevention and Treatment 2023-03-01
Series:Zhongliu Fangzhi Yanjiu
Subjects:
brentuximab vedotin
antibody-drug conjugate
lymphoma
prognosis
Online Access:http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2023.22.1235

Internet

http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2023.22.1235

Similar Items